PSA welcomes assistance for Tasmania’s hospital pharmacists

27 May 2024


The Pharmaceutical Society of Australia (PSA) welcomes targeted assistance for Tasmania’s hospital pharmacists.

The allowance announced by Minister for Health, Mental Health and Wellbeing Guy Barnett MP aims to attract and retain pharmacists practising across the Tasmanian Health Service including in Statewide Hospital Pharmacy.

PSA Tasmania branch President David Peachey said adequate staffing across Tasmania’s public hospitals is critical to strengthening patient care.

“Strengthening our hospital pharmacist workforce, ensuring that they are supported to do their jobs, is an important step in implementing recommendations from the 2023 Tasmanian Pharmacist Scope of Practice Review,” Mr Peachey said.

“We want to see a health system that values the role of hospital pharmacists, and supports them to practice to their top of scope, including through partnered pharmacist medication charting.

“There is more to be done to unlock the full potential of pharmacists across our health system, but a strong workforce is essential to delivering the benefits of practising to our full and top of scope.

“I thank Minister Barnett and the Rockliff Government for their recognition of the critical role pharmacists play in our health system, and their continued support for our profession,” Mr Peachey concluded.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Tas expands pharmacy services to UTI treatment

12 February 2024


The Pharmaceutical Society of Australia (PSA) welcomes the Tasmanian Government’s announcement that pharmacists will be authorised to supply treatment for uncomplicated urinary tract infections (UTIs) from March this year.

Every community pharmacist in Tasmania will be able to take part in additional training to offer the program which is modelled on services already operating in other states.

PSA Tasmania President David Peachey MPS said the move utilises the state’s most accessible health care professionals to continue supporting timely patient care.

“PSA welcomes Minister Barnett’s move to give Tasmanians greater access to safe health care when and where they need it,” Mr Peachey said.

“We have already seen UTI prescribing programs work successfully around the country – and in Queensland for quite a few years now.

“We know that around half of women will experience a UTI in their lifetime, and that timely access to treatment is key to alleviating discomfort and preventing further complications or hospitalisation.

“Pharmacists are key to strengthening the health care system. Regional and rural communities across Tasmania will benefit enormously from being able to access treatment from their local pharmacist, freeing up our hardworking rural GPs for more complex patient needs.”

PSA’s Managing uncomplicated cystitis training program is now available to all Tasmanian pharmacists. Successful completion allows the pharmacist to provide an assessment and treatment, if deemed appropriate, for uncomplicated UTIs in women aged 18 to 65, once the program commences from 1 March 2024.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Tasmanian pharmacists to support palliative care at home

18 January 2024


The Pharmaceutical Society of Australia (PSA) has partnered with the Tasmanian Government to help support palliative care patients stay at home and receive the care and medicines they need in a comfortable, familiar environment.

Announced by Health Minister Guy Barnett MP in Launceston today, the program supports community pharmacies across Tasmania to continuously stock essential palliative care medicines, ensuring these are available to patients across the state when needed.

PSA will deliver training in the provision of essential palliative care medicines for pharmacists and GPs as part of the program, ensuring the safe and quality use of medicines thanks to funding from the Tasmanian Department of Health.

PSA Tasmanian President David Peachey MPS said the joint approach demonstrated a commitment to improving palliative care for all Tasmanians.

“PSA is proud to be a part of this innovative program to improve services and support for palliative care patients within our community,” Mr Peachey said.

“Timely access to medicines to manage end of life symptoms is essential to a quality end of life journey for patients and their families. Palliative medications are needed within hours, not days, which is why it is so important that they are easily accessible within the community.

“Having more Tasmanian pharmacists educated and trained to supply palliative medicines means that we can make their safe and quality use more accessible to more people at the end of their lives,” Mr Peachey concluded.

PSA National President Dr Fei Sim FPS also welcomed the move, pointing to the growing role of pharmacists in palliative care following nation-wide consultation on the upcoming palliative care foundation training program.

“Upskilling local pharmacists in palliative care will increase the capacity of community palliative care teams, community pharmacists, and general practitioners to provide care to patients at the end of life,” she said.

“Pharmacists will increase collaboration and coordination of local palliative care services, reducing unnecessary hospital presentations.

“We look forward to evolving the support for pharmacists within the palliative care team as part of the ComPPaCT initiative,” Dr Sim concluded.

The pharmacist palliative care foundation training program will be available to all Australian registered pharmacists. More information and instruction on how to enrol will be communicated to PSA members in 2024.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au